| Primary |
| Irritable Bowel Syndrome |
55.5% |
| Drug Use For Unknown Indication |
27.6% |
| Diarrhoea |
3.9% |
| Product Used For Unknown Indication |
3.6% |
| Anxiety |
1.9% |
| Rheumatoid Arthritis |
1.9% |
| Abdominal Pain |
0.6% |
| Diarrhea |
0.6% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Staphylococcal Infection |
0.6% |
| Wound Infection |
0.6% |
| Arthralgia |
0.3% |
| Colitis |
0.3% |
| Colitis Collagenous |
0.3% |
| Diarrhoea Infectious |
0.3% |
| Inflammatory Bowel Disease |
0.3% |
| Nausea |
0.3% |
| Sleep Disorder |
0.3% |
|
| Gastrointestinal Injury |
18.0% |
| Colitis Ischaemic |
13.4% |
| Rectal Haemorrhage |
11.9% |
| Drug Ineffective |
10.8% |
| Adverse Event |
9.3% |
| Vomiting |
5.2% |
| Constipation |
4.1% |
| Death |
3.6% |
| Nausea |
3.6% |
| Haematochezia |
2.6% |
| Therapeutic Response Decreased |
2.6% |
| Weight Decreased |
2.1% |
| White Blood Cell Count Increased |
2.1% |
| Irritable Bowel Syndrome |
1.5% |
| Occult Blood Positive |
1.5% |
| Pain |
1.5% |
| Pancreatitis |
1.5% |
| Rash |
1.5% |
| Small Intestinal Obstruction |
1.5% |
| Weight Increased |
1.5% |
|
| Secondary |
| Drug Use For Unknown Indication |
37.5% |
| Irritable Bowel Syndrome |
37.5% |
| Diarrhoea |
12.5% |
| Gastrooesophageal Reflux Disease |
12.5% |
|
| Rectal Haemorrhage |
28.6% |
| Blood Chromogranin A Increased |
14.3% |
| Drug Ineffective |
14.3% |
| Intestinal Perforation |
14.3% |
| Pruritus |
14.3% |
| Vomiting |
14.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
42.0% |
| Irritable Bowel Syndrome |
6.0% |
| Bipolar Disorder |
5.3% |
| Pain |
4.7% |
| Premenstrual Syndrome |
4.7% |
| Contraception |
4.0% |
| Sleep Disorder |
4.0% |
| Depression |
3.3% |
| Blood Cholesterol Increased |
2.7% |
| Crohn's Disease |
2.7% |
| Hypertension |
2.7% |
| Multiple Sclerosis |
2.7% |
| Rheumatoid Arthritis |
2.7% |
| Barrett's Oesophagus |
2.0% |
| Blood Cholesterol |
2.0% |
| Diabetes Mellitus |
2.0% |
| Drug Use For Unknown Indication |
2.0% |
| Hypersensitivity |
2.0% |
| Arthritis |
1.3% |
| Asthenia |
1.3% |
|
| Emotional Distress |
8.7% |
| Galactorrhoea |
8.7% |
| Procedural Vomiting |
8.7% |
| Asthenia |
4.3% |
| Biliary Dyskinesia |
4.3% |
| Cellulitis |
4.3% |
| Clostridium Difficile Infection |
4.3% |
| Cyanosis |
4.3% |
| Decreased Appetite |
4.3% |
| Dizziness |
4.3% |
| Drug Ineffective |
4.3% |
| Gallbladder Disorder |
4.3% |
| Gastrooesophageal Reflux Disease |
4.3% |
| Generalised Erythema |
4.3% |
| Injection Site Discolouration |
4.3% |
| Injection Site Papule |
4.3% |
| Injection Site Pruritus |
4.3% |
| Irritable Bowel Syndrome |
4.3% |
| Lactation Disorder |
4.3% |
| Loss Of Consciousness |
4.3% |
|
